» Articles » PMID: 37749335

Cognitive Impairment in Heart Failure Patients: Association with Abnormal Circadian Blood Pressure Rhythm: a Review from the HOPE Asia Network

Overview
Journal Hypertens Res
Date 2023 Sep 25
PMID 37749335
Authors
Affiliations
Soon will be listed here.
Abstract

Cognitive impairment (CI) is frequently a comorbid condition in heart failure (HF) patients, and is associated with increased cardiovascular events and death. Numerous factors contribute to CI in HF patients. Decreased cerebral blood flow, inflammation, and activation of neurohumoral factors are all thought to be factors that exacerbate CI. Hypoperfusion of the brain due to decreased systemic blood flow, cerebral venous congestion, and atherosclerosis are the main mechanism of CI in HF patients. Abnormal circadian BP rhythm is one of the other conditions associated with CI. The conditions in which BP does not decrease sufficiently or increases during the night are called non-dipper or riser BP patterns. Abnormal circadian BP rhythm worsens CI in HF patients through cerebral congestion during sleep and atherosclerosis due to pressure overload. Interventions for CI in HF patients include treatment for HF itself using cardiovascular drugs, and treatment for fluid retention, one of the causes of abnormal circadian rhythms. Proposed pathways of cognitive impairment in heart failure through abnormal circadian blood pressure rhythm.

Citing Articles

Mapping research on cognitive impairment in heart failure patients: A bibliometric analysis from 2013 to 2022.

Zhao Q, Zhu X, Wan X, Wu J, Shen F, Bian F Heliyon. 2024; 10(19):e38955.

PMID: 39430440 PMC: 11490794. DOI: 10.1016/j.heliyon.2024.e38955.


Sleep quality associate with the increased prevalence of cognitive impairment in coronary artery disease patients: A retrospective case-control study.

Liu M, Ma J, Bao K, Gu Y, Zhao J, Ren D Open Med (Wars). 2024; 19(1):20241034.

PMID: 39291285 PMC: 11406142. DOI: 10.1515/med-2024-1034.


Hypertension: Causes and Consequences of Circadian Rhythms in Blood Pressure.

Faraci F, Scheer F Circ Res. 2024; 134(6):810-832.

PMID: 38484034 PMC: 10947115. DOI: 10.1161/CIRCRESAHA.124.323515.


Peripheral inflammation and neurocognitive impairment: correlations, underlying mechanisms, and therapeutic implications.

Tan S, Chen W, Kong G, Wei L, Xie Y Front Aging Neurosci. 2023; 15:1305790.

PMID: 38094503 PMC: 10716308. DOI: 10.3389/fnagi.2023.1305790.

References
1.
Okura Y, Ramadan M, Ohno Y, Mitsuma W, Tanaka K, Ito M . Impending epidemic: future projection of heart failure in Japan to the year 2055. Circ J. 2008; 72(3):489-91. DOI: 10.1253/circj.72.489. View

2.
Tsao C, Aday A, Almarzooq Z, Alonso A, Beaton A, Bittencourt M . Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation. 2022; 145(8):e153-e639. DOI: 10.1161/CIR.0000000000001052. View

3.
Bahrami H, Kronmal R, Bluemke D, Olson J, Shea S, Liu K . Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis. Arch Intern Med. 2008; 168(19):2138-45. PMC: 3038918. DOI: 10.1001/archinte.168.19.2138. View

4.
Bragazzi N, Zhong W, Shu J, Much A, Lotan D, Grupper A . Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017. Eur J Prev Cardiol. 2021; 28(15):1682-1690. DOI: 10.1093/eurjpc/zwaa147. View

5.
Alosco M, Spitznagel M, Van Dulmen M, Raz N, Cohen R, Sweet L . Cognitive function and treatment adherence in older adults with heart failure. Psychosom Med. 2012; 74(9):965-73. PMC: 3498588. DOI: 10.1097/PSY.0b013e318272ef2a. View